Medical Radioactive Isotopes Market By Type, Application, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : March 2022 Pages : 106 Category: Pharmaceuticals Report Code : HC0317337
The global Medical Radioactive Isotopes Market is valued at USD 7386.75 million in 2021 and is projected to reach USD XX million by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
Radioactive isotopes are species of chemical elements that are produced through the natural decay of atoms. Exposure to radiation generally is considered harmful to the human body, but radioisotopes are highly valuable in medicine, particularly in the diagnosis and treatment of disease. Radioactive isotopes have many useful applications. In medicine, for example, cobalt-60 is extensively employed as a radiation source to arrest the development of cancer. Other radioactive isotopes are used as tracers for diagnostic purposes as well as in research on metabolic processes. When a radioactive isotope is added in small amounts to comparatively large quantities of the stable element, it behaves exactly the same as the ordinary isotope chemically.
The report exhibit detail coverage of Medical Radioactive Isotopes industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2027-2027. This research study of Medical Radioactive Isotopes Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Medical Radioactive Isotopes Market for 2022-2027.
Crystal Market Research envisions that the span of the Medical Radioactive Isotopes Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Medical Radioactive Isotopes in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Medical Radioactive Isotopes Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Medical Radioactive Isotopes Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- NRG
- IRE
- ANSTO
- NTP Radioisotopes
- China National Nuclear Corporation
- Rosatom
- Nordion
- Eckert & Ziegler Strahlen
- Polatom
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Medical Radioactive Isotopes Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Tc-99m
o Cobalt-60
o Iodine Radioisotopes
· Medical Radioactive Isotopes Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Nuclear Therapy
o Equipment Radioactive Source
o Diagnosis
o Others
· Medical Radioactive Isotopes Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o NRG
o IRE
o ANSTO
o NTP Radioisotopes
o China National Nuclear Corporation
o Rosatom
o Nordion
o Eckert & Ziegler Strahlen
o Polatom
· Medical Radioactive Isotopes Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Medical Radioactive Isotopes Market, By Country
o U.S. Medical Radioactive Isotopes Market
o Canada Medical Radioactive Isotopes Market
o Mexico Medical Radioactive Isotopes Market
o Europe
§ Europe Medical Radioactive Isotopes Market, By Country
o UK Medical Radioactive Isotopes Market
o Germany Medical Radioactive Isotopes Market
o France Medical Radioactive Isotopes Market
o Russia Medical Radioactive Isotopes Market
o Italy Medical Radioactive Isotopes Market
o Rest of Europe Medical Radioactive Isotopes Market
o Asia-Pacific
§ Asia-Pacific Medical Radioactive Isotopes Market, By Country
o China Medical Radioactive Isotopes Market
o Japan Medical Radioactive Isotopes Market
o South Korea Medical Radioactive Isotopes Market
o India Medical Radioactive Isotopes Market
o Southeast Asia Medical Radioactive Isotopes Market
o Rest of Asia-Pacific Medical Radioactive Isotopes Market
o South America
§ South America Medical Radioactive Isotopes Market
o Brazil Medical Radioactive Isotopes Market
o Argentina Medical Radioactive Isotopes Market
o Columbia Medical Radioactive Isotopes Market
o Rest of South America Medical Radioactive Isotopes Market
o Middle East and Africa
§ Middle East and Africa Medical Radioactive Isotopes Market
o Saudi Arabia Medical Radioactive Isotopes Market
o UAE Medical Radioactive Isotopes Market
o Egypt Medical Radioactive Isotopes Market
o Nigeria Medical Radioactive Isotopes Market
o South Africa Medical Radioactive Isotopes Market
o Turkey Medical Radioactive Isotopes Market
o Rest of MEA Medical Radioactive Isotopes Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Medical Radioactive Isotopes Market, By Type
5.1. Introduction
5.2. Global Medical Radioactive Isotopes Revenue and Market Share by Type (2017-2021)
5.2.1. Global Medical Radioactive Isotopes Revenue and Revenue Share by Type (2017-2021)
5.3. Tc-99m
5.3.1. Global Tc-99m Revenue and Growth Rate (2017-2021)
5.4. Cobalt-60
5.4.1. Global Cobalt-60 Revenue and Growth Rate (2017-2021)
5.5. Iodine Radioisotopes
5.5.1. Global Iodine Radioisotopes Revenue and Growth Rate (2017-2021)
6. Medical Radioactive Isotopes Market, By Application
6.1. Introduction
6.2. Global Medical Radioactive Isotopes Revenue and Market Share by Application (2017-2021)
6.2.1. Global Medical Radioactive Isotopes Revenue and Revenue Share by Application (2017-2021)
6.3. Nuclear Therapy
6.3.1. Global Nuclear Therapy Revenue and Growth Rate (2017-2021)
6.4. Equipment Radioactive Source
6.4.1. Global Equipment Radioactive Source Revenue and Growth Rate (2017-2021)
6.5. Diagnosis
6.5.1. Global Diagnosis Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Medical Radioactive Isotopes Market, By Region
7.1. Introduction
7.2. Global Medical Radioactive Isotopes Revenue and Market Share by Regions
7.2.1. Global Medical Radioactive Isotopes Revenue by Regions (2017-2021)
7.3. North America Medical Radioactive Isotopes by Countries
7.3.1. North America Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
7.3.2. North America Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Medical Radioactive Isotopes by Countries
7.4.1. Europe Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
7.4.2. Europe Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Medical Radioactive Isotopes by Countries
7.5.1. Asia-Pacific Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Medical Radioactive Isotopes by Countries
7.6.1. South America Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
7.6.2. South America Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Medical Radioactive Isotopes by Countries
7.7.1. Middle East and Africa Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. NRG
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. IRE
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. ANSTO
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. NTP Radioisotopes
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. China National Nuclear Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Rosatom
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Nordion
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Eckert & Ziegler Strahlen
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Polatom
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Medical Radioactive Isotopes Market Forecast (2022-2027)
9.1. Global Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Medical Radioactive Isotopes Market Forecast by Regions (2022-2027)
9.2.1. North America Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.1.1. United States Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.1.2. Canada Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.1.3. Mexico Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2. Europe Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.1. Germany Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.2. France Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.3. UK Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.4. Russia Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.5. Italy Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3. Asia-Pacific Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.1. China Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.2. Japan Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.3. Korea Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.4. India Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.4. South America Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.4.1. Brazil Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.4.2. Argentina Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.4.3. Columbia Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.4.4. Rest of South America Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5. Middle East and Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.3. Egypt Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.4. Nigeria Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.5. South Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.6. Turkey Medical Radioactive Isotopes Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
9.3. Medical Radioactive Isotopes Market Forecast by Type (2022-2027)
9.3.1. Medical Radioactive Isotopes Forecast by Type (2022-2027)
9.3.2. Medical Radioactive Isotopes Market Share Forecast by Type (2022-2027)
9.4. Medical Radioactive Isotopes Market Forecast by Application (2022-2027)
9.4.1. Medical Radioactive Isotopes Forecast by Application (2022-2027)
9.4.2. Medical Radioactive Isotopes Market Share Forecast by Application (2022-2027)
10. List of Tables and Figures
Figure United States Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Medical Radioactive Isotopes Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Medical Radioactive Isotopes Revenue and Revenue Share by Type (2017-2021)
Figure Global Tc-99m Revenue and Growth Rate (2017-2021)
Figure Global Cobalt-60 Revenue and Growth Rate (2017-2021)
Figure Global Iodine Radioisotopes Revenue and Growth Rate (2017-2021)
Table Global Medical Radioactive Isotopes Revenue and Revenue Share by Application (2017-2021)
Figure Global Nuclear Therapy Revenue and Growth Rate (2017-2021)
Figure Global Equipment Radioactive Source Revenue and Growth Rate (2017-2021)
Figure Global Diagnosis Revenue and Growth Rate (2017-2021)
Figure Global Others Revenue and Growth Rate (2017-2021)
Table Global Medical Radioactive Isotopes Revenue by Regions (2017-2021)
Figure North America Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure North America Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
Figure North America Medical Radioactive Isotopes by Countries (2017-2021)
Figure North America Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
Figure United States Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure United States Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Canada Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Canada Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Mexico Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Mexico Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Europe Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Europe Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
Figure Europe Medical Radioactive Isotopes by Countries (2017-2021)
Figure Europe Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
Figure Germany Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Germany Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure France Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure France Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure UK Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure UK Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Russia Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Russia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Italy Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Italy Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Europe Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Rest of Europe Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Asia-Pacific Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Asia-Pacific Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
Figure Asia-Pacific Medical Radioactive Isotopes by Countries (2017-2021)
Figure Asia-Pacific Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
Figure China Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure China Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Japan Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Japan Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Korea Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Korea Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure India Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure India Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Southeast Asia Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Southeast Asia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Asia-Pacific Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Rest of Asia-Pacific Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South America Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure South America Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
Figure South America Medical Radioactive Isotopes by Countries (2017-2021)
Figure South America Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
Figure Brazil Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Brazil Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Argentina Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Argentina Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Columbia Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Columbia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of South America Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Rest of South America Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Middle East and Africa Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Middle East and Africa Medical Radioactive Isotopes Revenue and Growth Rate (2017-2021)
Figure Middle East and Africa Medical Radioactive Isotopes by Countries (2017-2021)
Figure Middle East and Africa Medical Radioactive Isotopes Revenue (Million USD) by Countries (2017-2021)
Figure Saudi Arabia Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Saudi Arabia Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure United Arab Emirates Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure United Arab Emirates Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Egypt Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Egypt Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Nigeria Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Nigeria Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South Africa Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure South Africa Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Turkey Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Turkey Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Middle East and Africa Medical Radioactive Isotopes Growth Rate (2017-2021)
Figure Rest of Middle East and Africa Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2017-2021)
Table NRG Medical Radioactive Isotopes Financial Overview
Table IRE Medical Radioactive Isotopes Financial Overview
Table ANSTO Medical Radioactive Isotopes Financial Overview
Table NTP Radioisotopes Medical Radioactive Isotopes Financial Overview
Table China National Nuclear Corporation Medical Radioactive Isotopes Financial Overview
Table Rosatom Medical Radioactive Isotopes Financial Overview
Table Nordion Medical Radioactive Isotopes Financial Overview
Table Eckert & Ziegler Strahlen Medical Radioactive Isotopes Financial Overview
Table Polatom Medical Radioactive Isotopes Financial Overview
Figure Global Medical Radioactive Isotopes Revenue (Millions USD) and Growth Rate (2022-2027)
Table Medical Radioactive Isotopes Market Forecast by Regions (2022-2027)
Figure North America Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure United States Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Canada Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Mexico Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Europe Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Germany Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure France Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure UK Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Russia Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Italy Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Rest of Europe Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Asia-Pacific Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure China Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Japan Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Korea Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure India Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Southeast Asia Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Rest of Asia-Pacific Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure South America Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Brazil Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Argentina Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Columbia Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Rest of South America Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Middle East and Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Saudi Arabia Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure United Arab Emirates Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Egypt Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Nigeria Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure South Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Turkey Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Rest of Middle East and Africa Medical Radioactive Isotopes Market Forecast (2022-2027)
Figure Global Medical Radioactive Isotopes Forecast by Type (2022-2027)
Figure Global Medical Radioactive Isotopes Market Share Forecast by Type (2022-2027)
Figure Global Medical Radioactive Isotopes Forecast by Type (2022-2027)
Figure Global Medical Radioactive Isotopes Forecast by Application (2022-2027)
Figure Global Medical Radioactive Isotopes Market Share Forecast by Application (2022-2027)
Figure Global Medical Radioactive Isotopes Forecast by Application (2022-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|